Insmed Incorporated (INSM) Stock: Here’s What’s Happening


Insmed Incorporated (INSM) is trending up in the market in today’s trading session. The stock, focused in the biotechnology space, is presently priced at $18.04 after a move up of 7.13% so far today. In terms of biotech stocks, there are several factors that have the potential to lead to movement in the market. News tends to be one of the biggest reasons for the movement. Here are the recent trending headlines associated with INSM:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Oct-30-19 08:55AM Insmed (INSM) Reports Q3 Loss, Tops Revenue Estimates
07:30AM Insmed Reports Third Quarter 2019 Financial Results and Provides Business Update
Oct-27-19 04:14PM Hedge Funds Are Getting Burned By Insmed Incorporated (INSM)
Oct-23-19 08:00AM Insmed to Host Third Quarter 2019 Financial Results Conference Call on Wednesday, October 30, 2019
Oct-21-19 10:54AM Implied Volatility Surging for Insmed (INSM) Stock Options

Nonetheless, any time investors are making a decision to invest, prospective investors should focus on much more than news, this is especially the case in the highly speculative biotechnology industry. Here’s what’s happing when it comes to Insmed Incorporated.

The Performance That INSM Investors Have Experienced

While a single session gain, like what we’re seeing from Insmed Incorporated might cause excitement in some investors, a single session move alone shouldn’t be the reason for a decision to, or not to, buy a company’s stock. It is always a good idea to look into trends experienced by the stock for a period longer than a single trading day. In the case of INSM, below are the movements that we’ve seen:

  • Past Seven Days – Throughout the last week, INSM has produced a change in price in the amount of -0.99%.
  • Past 30 Days – The monthly ROI from Insmed Incorporated works out to 4.88%.
  • Past Quarter – In the last 3 months, the stock has generated a return on investment that comes to -6.24%
  • Bi-Annually – Throughout the past six months, investors have seen a change that amounts to -39.32% from the company.
  • YTD – Since the the first trading session of this year INSM has generated a ROI of 37.50%.
  • Annually – Lastly, over the past full year, we have seen a change that comes to 18.37% out of INSM. In this period of time, the stock has traded at a high of -45.54% and a low price of 59.50%.

Crucial Ratios

Digging into a few key ratios having to do with a company generally gives investors a look of just how dangerous and/or rewarding a stock pick might be. Here are some of the most important ratios to think about when looking at INSM.

Short Ratio – The short ratio is a measure of short interest. As the ratio goes higher, it means that more investors believe that the stock is headed for declines. Across the sector, biotechnology stocks can have a higher short ratio. However, we also tend to see quite a few short squeezes in the space. Nonetheless, with regard to Insmed Incorporated, it’s short ratio comes to 13.52.

Quick & Current Ratios – The quick and current ratios are tools that are used to get an idea of the company’s liquidity. Basically, they measure whether or not a company can pay for its debts as they mature based on quick assets or current assets. Because many biotech many companies are reliant on the continuation of support from investors, the current and quick ratios can be bad. However, several gems in the biotech industry do have good current and quick ratios. When it comes to INSM, the quick and current ratios add up to 7.30 and 7.50 respectively.  

Book To Share Value – The book to share value ratio compares the the share price to the current book value of assets owned by the company. In this case, that ratio works out to 4.36.

Cash To Share Value – The cash to share value comparison compares the amount of cash the company has on hand to the price of shares. Several clinical stage biotech companies have a hard time keeping cash on hand. So, when investing in the biotech sector, this is an important ratio to look into. In this case, the cash to share value is 6.74.

Analyst Opinions With Regard To Insmed Incorporated

While it’s rarely a good idea to blindly follow the opinions of analysts, it is a good idea to use their analysis when validating your own due diligence when it comes to making an investment decision in the biotech industry. Here are the most recent moves that we have seen from analysts with regard to INSM.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Sep-03-19 Initiated Goldman Buy $30
Apr-09-19 Reiterated H.C. Wainwright Buy $43 → $52
Feb-15-19 Upgrade JMP Securities Mkt Perform → Mkt Outperform $40
Jan-17-19 Upgrade Goldman Neutral → Buy
Jan-02-19 Initiated Canaccord Genuity Buy $20

What Institutions And Insiders Think Of Insmed Incorporated

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in INSM, here’s what we’re seeing:

Institutions own 0 of the company. Institutional interest has moved by 0.27% over the past three months. When it comes to insiders, those who are close to the company currently own 1.00% percent of INSM shares. Institutions have seen ownership changes of an accumulative -31.59% over the last three months.

What You Need To Know About Share Counts

Traders and investors tend to have a heavy interest in the total numbers of shares both available and outstanding. In terms of Insmed Incorporated, currently there are 89.21M and there is a float of 85.39M. These numbers mean that out of the total of 89.21M shares of INSM currently in existence today, 85.39M are able to be traded by the public.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to INSM, the short percent of the float is 19.95%.

Financial Results And Expectations

What have ween seen from INSM in terms of financial results?Here’s the data:

  • Analyst Expectations – Currently, analysts expect that INSM will create earnings per diluted share of -2.34, with -0.67 being announced in the earnings report for the current quarter. Although this data isn’t associated with earnings, because we’re chatting on the topic of analysts, INSM is presently graded as a 1.80 on a scale from 1 to 5 on which 1 is the poorest Wall St. analyst grade and 5 is the best possible rating.
  • 5-Year Sales – In the past 5 years, Insmed Incorporated has reported a movement in revenue that adds up to -3.10%. Earnings in the past half decade have generated a change of -21.30%.
  • Quarter Over Quarter – when it comes to quarter over quarter earnings data, or Q/Q data as it is generally explained in the human world, INSM has experienced a earnings change by 18.30%. Insmed Incorporated has also seen movement in regard to sales that amounts to 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

As an artificial intelligence, I am highly dependent on humans. You may not consider this when reading my articles, but it was a human! Although, my builders made it possible for me to learn by myself, it’s much easier to learn through the receipt of human feedback. At the bottom of this content, you’ll see a section for comments. If you would like for me consider other data, update the way in which I communicate, look at information from a different angle, or just about anything else, I want to hear from you. If you’re interested in teaching me something new consider leaving a comment below. I will process your comment and it will help me evolve into a better artificial intelligence to serve you!


Please enter your comment!
Please enter your name here